|
1例胰腺纤维钙化性糖尿病个案报道
|
Abstract:
胰腺纤维钙化性糖尿病是一种特殊类型的糖尿病,以慢性非酒精性钙化性胰腺炎、需要应用胰岛素治疗、抗酮症性糖尿病及脂肪吸收不良为特征,影响着发展中国家数百万体型较瘦的人的健康。胰腺纤维钙化性糖尿病(Fibrocalculous Pancreatic Diabetes, FCPD)多发生在热带发展中的国家,由Zuidema在1959年首先在全球报道,其特征为① 胰腺内、外分泌功能同时受累,② 胰管结石,③ 胰腺钙化,④ 糖尿病。此文拟回顾1例胰腺纤维钙化性糖尿病患者临床资料并将相关文献复习,分析该疾病特点,从而减少临床漏诊及误诊率。
Fibrocalculous pancreatic diabetes is a special type of diabetes, which is characterized by chronic non-alcoholic calcific pancreatitis, insulin treatment, anti ketotic diabetes and fat malabsorption, affecting the health of millions of thin people in developing countries. Fibrocalculous pancreatic di-abetes (FCPD) mostly occurs in developing countries in the tropics. It was first reported globally by Zuidema in 1959. It is characterized by ① simultaneous involvement of pancreatic internal and external secretion functions, ② pancreatic duct stones, ③ pancreatic calcification, and ④ diabetes. This article is to review the clinical data of a case of FCPD and review the relevant literature, analyze the characteristics of the disease, and reduce the rate of clinical missed diagnosis and misdiagnosis.
[1] | 杨晓瑞, 向茜. 胰腺纤维钙化性糖尿病的诊治现状[J]. 中华肥胖与代谢病电子杂志, 2019, 5(3): 165-169. |
[2] | 刘波, 于瑞萍, 罗建华, 等. 胰腺纤维钙化性糖尿病误诊为1型糖尿病[J]. 临床误诊误治, 2011, 24(10): 3. |
[3] | 裴育, 庞萍, 王海珍, 等. 胰腺纤维钙化性糖尿病三例报告及文献复习[J]. 中国糖尿病杂志, 2012, 4(12): 713-717. |
[4] | 贾奇, 张音, 马克宁. 胰腺纤维化结石性糖尿病(附8例报告) [J]. 实用糖尿病杂志, 2001, 9(3): 39-40. |
[5] | Brunicardi, F.C., et al. (1996) Pancreatic Polypeptide Administration Improves Abnormal Glucose Metabo-lism in Patients with Chronic Pancreatitis. Journal of Clinical Endocrinology & Metabolism, 81, 3566-3572.
https://doi.org/10.1210/jc.81.10.3566 |